A newly published commentary in Nature Health explores how low- and middle-income countries can strengthen pathogen genomics capacity by prioritizing locally relevant applications that directly inform public health action. Rather than focusing only on global surveillance needs, the paper argues that sustainable genomics investments are most effective when they help countries answer urgent national questions, such as monitoring antimicrobial resistance, guiding treatment decisions, informing vaccine policy and improving outbreak detection and response.
The commentary outlines how genomics can become a practical, routine tool for public health when sequencing efforts are tied to clear decision-making pathways and country priorities.
Co-authored by leaders in global health and genomics, led by Dr. Greg Armstrong and including Dr. Joseph Bresee, PIVI Director, the publication reflects PIVI’s broader commitment to helping countries strengthen the systems, technical capacity and evidence needed to respond to infectious disease threats. Read more